PYRILAMINE MALEATE Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Pyrilamine Maleate, and what generic alternatives are available?
Pyrilamine Maleate is a drug marketed by Impax Labs and Watson Labs and is included in two NDAs.
The generic ingredient in PYRILAMINE MALEATE is pyrilamine maleate. There are seven drug master file entries for this compound. Additional details are available on the pyrilamine maleate profile page.
Summary for PYRILAMINE MALEATE
US Patents: | 0 |
Applicants: | 2 |
NDAs: | 2 |
Raw Ingredient (Bulk) Api Vendors: | 61 |
Patent Applications: | 1,100 |
Formulation / Manufacturing: | see details |
DailyMed Link: | PYRILAMINE MALEATE at DailyMed |
Medical Subject Heading (MeSH) Categories for PYRILAMINE MALEATE
US Patents and Regulatory Information for PYRILAMINE MALEATE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Impax Labs | PYRILAMINE MALEATE | pyrilamine maleate | TABLET;ORAL | 080808-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Watson Labs | PYRILAMINE MALEATE | pyrilamine maleate | TABLET;ORAL | 085231-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |